Open AccessThe Role of Radiation Therapy in Addition to Lumpectomy and Hormone Therapy in Men 70 Years of Age and Older with Early Breast Cancer: A NCDB Analysis
Author(s) -
Sarah B. Bateni,
Lauren M Perry,
Xiao Zhao,
Ali Mili,
Megan E. Daly,
Susan L. Stewart,
Richard J. Bold,
Robert J. Canter,
Candice A. M. Sauder
Publication year - 2020
Publication title -
annals of surgical oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.764
H-Index - 173
eISSN - 1534-4681
pISSN - 1068-9265
DOI - 10.1245/s10434-020-09242-7
Subject(s) - lumpectomy , medicine , mastectomy , breast cancer , surgical oncology , radiation therapy , oncology , cancer , proportional hazards model , stage (stratigraphy) , gynecology , paleontology , biology
Current treatment guidelines for male breast cancer are guided by female-only trials despite data suggesting distinct clinicopathologic differences between sexes. We sought to evaluate whether radiation therapy (RT) after lumpectomy was associated with equivalent survival among men > 70 years of age with stage I, estrogen receptor (ER) positive tumors, as seen in women from the Cancer and Leukemia Group B (CALGB) 9343 trial.